UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Current medicinal chemistry, ISSN 0929-8673, 03/2016, Volume 23, Issue 8, pp. 774 - 791
Natural drug | Polyphenol | Morin | Anti-oxidant | Anti-diabetic | Anti-inflammatory | Flavonoid | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Antihypertensive Agents - pharmacology | Antioxidants - chemistry | Hypoglycemic Agents - metabolism | Antioxidants - metabolism | Humans | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Biological Products - pharmacology | Antihypertensive Agents - metabolism | Neuroprotective Agents - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Antineoplastic Agents - metabolism | Neuroprotective Agents - pharmacology | Anti-Bacterial Agents - chemistry | Antineoplastic Agents - pharmacology | Flavonoids - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Neuroprotective Agents - chemistry | Anti-Bacterial Agents - metabolism | Hypoglycemic Agents - chemistry | Antioxidants - pharmacology | Antineoplastic Agents - chemistry | Hypoglycemic Agents - pharmacology | Antihypertensive Agents - chemistry | Biological Products - chemistry | Animals | Flavonoids - metabolism | Biological Products - metabolism | Anti-Bacterial Agents - pharmacology | Flavonoids - chemistry | Index Medicus
Journal Article
American Journal of Physiology - Cell Physiology, ISSN 0363-6143, 08/2007, Volume 293, Issue 2, pp. 509 - 536
Cell proliferation | Arterial hypertension | Endogenous cardiotonic steroids | Rostafuroxin | Sodium/potassium-adenosinetriphosphatase | Cancer therapy | Ouabain | Marinobufagenin | Sodium pump | Oleandrin | Bufalin | Sodium metabolism | Physiology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Cardiac Glycosides - pharmacology | Neoplasms - metabolism | Antihypertensive Agents - pharmacology | Digoxin - metabolism | Calcium - metabolism | Humans | Myocardial Contraction - drug effects | Hypertension - drug therapy | Antineoplastic Agents - therapeutic use | Structure-Activity Relationship | Antihypertensive Agents - metabolism | Ouabain - metabolism | Antineoplastic Agents - metabolism | Bufanolides - metabolism | Antineoplastic Agents - pharmacology | Blood Pressure - drug effects | Molecular Structure | Cell Death - drug effects | Sodium Chloride - metabolism | Ouabain - pharmacology | Sodium-Potassium-Exchanging ATPase - antagonists & inhibitors | Diabetes Mellitus - metabolism | Cardiovascular System - drug effects | Antihypertensive Agents - therapeutic use | Antineoplastic Agents - chemistry | Digoxin - pharmacology | Hypertension - physiopathology | Hypertension - metabolism | Neoplasms - drug therapy | Antihypertensive Agents - chemistry | Sodium-Potassium-Exchanging ATPase - metabolism | Animals | Myocytes, Cardiac - drug effects | Cardiovascular System - metabolism | Diabetes Mellitus - physiopathology | Cardiac Glycosides - chemistry | Myocytes, Cardiac - metabolism | Bufanolides - pharmacology | Cardiac Glycosides - metabolism | Cardiac Glycosides - therapeutic use | Cell Proliferation - drug effects | Neoplasms - pathology | Hypertension | Cell growth | Hypotheses | Metabolism | Gene expression | Steroids | Index Medicus
Journal Article
Nutrients, ISSN 2072-6643, 07/2018, Volume 10, Issue 7, p. 921
Hypertension | Obesity | Watermelon | Liver | Cardiovascular disease | Inflammation | Adipocytes | Endothelial function | Supplements | Enterocytes | Mitochondria | Interventions | Arginine | Nitric oxide | Flow mediated dilation | Therapeutics | Aging | Insulin resistance | Muscle | Diabetes | Immune cells | Life Sciences & Biomedicine | Nutrition & Dietetics | Science & Technology | Vasodilator Agents - therapeutic use | Hypoglycemic Agents - metabolism | Antioxidants - metabolism | Humans | Citrulline - metabolism | Metabolic Syndrome - metabolism | Antihypertensive Agents - metabolism | Diabetic Angiopathies - physiopathology | Vasodilator Agents - metabolism | Metabolic Syndrome - physiopathology | Hypertension - prevention & control | Metabolic Syndrome - immunology | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Diabetic Angiopathies - prevention & control | Dietary Supplements - adverse effects | Vascular Stiffness | Sarcopenia - metabolism | Endothelium, Vascular - immunology | Hypoglycemic Agents - therapeutic use | Diabetic Angiopathies - metabolism | Sarcopenia - immunology | Endothelium, Vascular - physiopathology | Insulin Resistance | Metabolic Syndrome - therapy | Hypertension - immunology | Citrulline - therapeutic use | Antihypertensive Agents - therapeutic use | Evidence-Based Medicine | Citrulline - adverse effects | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Hypertension - metabolism | Antioxidants - therapeutic use | Sarcopenia - physiopathology | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Endothelium, Vascular - metabolism | Models, Biological | Sarcopenia - prevention & control | Diabetic Angiopathies - immunology | Antioxidants - adverse effects | Vasodilator Agents - adverse effects | Hypoglycemic Agents - adverse effects | Health | Dietary supplements | Muscles | Amino acids | Gastrointestinal tract | Bioavailability | Citrulline | Metabolism | Nitric-oxide synthase | Substrates | Urea | L-citrulline | Synthesis | Gastrointestinal system | Blood pressure | Adults | Supplementation | Age | Index Medicus | endothelial function | cardiovascular disease | therapeutics | nitric oxide | liver | mitochondria | immune cells | enterocytes | supplements | interventions | arginine | inflammation | muscle | watermelon | aging | adipocytes | hypertension | insulin resistance | diabetes | obesity | flow mediated dilation
Journal Article
Drug metabolism and disposition, ISSN 0090-9556, 09/2012, Volume 40, Issue 9, pp. 1744 - 1756
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Antihypertensive Agents - pharmacology | Tetrazoles - pharmacology | Species Specificity | Valsartan | Hypoglycemic Agents - metabolism | Benzoates - metabolism | Humans | Antihypertensive Agents - metabolism | Hepatocytes - metabolism | Angiotensin II Type 1 Receptor Blockers - pharmacology | Angiotensin II Type 1 Receptor Blockers - metabolism | Organic Anion Transporters - metabolism | Pyrimidines - metabolism | Quinolines - pharmacology | Tetrazoles - metabolism | Carbamates - metabolism | Dose-Response Relationship, Drug | Fluorobenzenes - pharmacology | Drug Interactions | Hydroxymethylglutaryl-CoA Reductase Inhibitors - metabolism | Biological Transport | Piperidines - pharmacology | Hepatocytes - drug effects | Carbamates - pharmacology | Pravastatin - pharmacology | Fluorobenzenes - metabolism | Piperidines - metabolism | Pravastatin - metabolism | Valine - analogs & derivatives | Rats | Rosuvastatin Calcium | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Hypoglycemic Agents - pharmacology | Quinolines - metabolism | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Valine - metabolism | Models, Biological | Benzimidazoles - metabolism | Sulfonamides - metabolism | Benzoates - pharmacology | Benzimidazoles - pharmacology | Kinetics | Valine - pharmacology | Organic Anion Transporters - drug effects | Index Medicus
Journal Article
Pharmacology & therapeutics (Oxford), ISSN 0163-7258, 01/2014, Volume 141, Issue 1, pp. 92 - 116
Drug metabolism | UDP-glucuronosyltransferases | Pharmacogenetics | Pharmacogenetics-based dose adjustments | UGT1A1 | Polymorphism | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions | Psychotropic Drugs - pharmacokinetics | Humans | Analgesics - metabolism | Analgesics - pharmacokinetics | Antihypertensive Agents - metabolism | Antihypertensive Agents - pharmacokinetics | Uridine Diphosphate - metabolism | Polymorphism, Genetic | Antineoplastic Agents - metabolism | Glucuronosyltransferase - genetics | Pharmaceutical Preparations - metabolism | Glucuronosyltransferase - metabolism | Anti-HIV Agents - pharmacokinetics | Antineoplastic Agents - pharmacokinetics | Psychotropic Drugs - metabolism | Anti-HIV Agents - metabolism | Pharmaceutical Preparations - administration & dosage | Pharmacokinetics | Physiological aspects | Xenobiotics | Index Medicus
Journal Article